Amanda L Kong, MD, MS, FACS | Medical College of Wisconsin

Amanda L. Kong, MD, MS, FACS

Associate Professor; Chief, Section of Breast Surgery

view physician profile

Locations

Froedtert Hospital
Breast Care Center - Froedtert
Mequon Health Center

Specialties

Surgical Oncology
General Surgery

Languages

French, English

Secondary Appointments

General Surgery

Contact Information

Research Interests

Dr. Kong is a breast surgical oncologist with a clinical and research focus in breast cancer and benign breast diseases. She joined the CAPS group (formerly known as PCOR) while completing her Master’s Degree in Epidemiology at the Medical College of Wisconsin. Her clinical practice provides the foundation for her research to help improve the care of her patients. She has an interest in quality of care and health care disparities with respect to breast cancer outcomes. Her current research focuses on the relationship between hospital volume and breast cancer care, including differences in processes of care in high- and low-volume hospitals and their impact on mortality through the use of large administrative databases and tumor registries.

Breast Cancer in Women Aged 80 Years or Older: An Analysis of Treatment Patterns and Disease Outcomes.

(Ferrigni E, Bergom C, Yin Z, Szabo A, Kong AL.) Clin Breast Cancer. 2019 Jan 31.
Management of the axilla after neo-adjuvant chemotherapy for breast cancer: Sentinel node biopsy and radiotherapy considerations.

(Currey A, Patten CR, Bergom C, Wilson JF, Kong AL.) Breast J. 2018 Nov;24(6):902-910.
The relationship between patient and tumor characteristics, patterns of breast cancer care, and 5-year survival among elderly women with incident breast cancer.

(Kong AL, Nattinger AB, McGinley E, Pezzin LE.) Breast Cancer Res Treat. 2018 Sep;171(2):477-488.
Fractures in a nationwide population-based cohort of users of breast cancer hormonal therapy.

(Neuner JM, Shi Y, Kong AL, Kamaraju S, Smith EC, Smallwood AJ, Laud PW, Charlson JA.) J Cancer Surviv. 2018 04;12(2):268-275.
Risk reduction and survival benefit of prophylactic surgery in BRCA mutation carriers, a systematic review.

(Ludwig KK, Neuner J, Butler A, Geurts JL, Kong AL.) Am J Surg. 2016 Oct;212(4):660-669.
Identifying patterns of breast cancer care provided at high-volume hospitals: a classification and regression tree analysis.

(Kong AL, Pezzin LE, Nattinger AB.) Breast Cancer Res Treat. 2015 Oct;153(3):689-98.
Benign Arterial Calcification on Screening Mammogram: A Marker for Coronary Artery Disease?

(Karm D, Marks DS, Wein M, Kong AL.) J Womens Health (Larchmt). 2015 Oct;24(10):795-800.
Racial differences in the surgical management of papillary lesions diagnosed by core needle biopsy.

(Kong AL, Saving A, Rathke S, Basir Z, Yen TW.) Breast J. 2015 Mar-Apr;21(2):203-4.
A one-to-one mentoring support service for breast cancer survivors.

(Amin AL, Neuner J, Duthie EA, Finn VR, Kong AL.) WMJ. 2014 Oct;113(5):185-9.
The effect of margin status and molecular subtype on women with invasive breast cancer treated with breast-conservation therapy.

(Currey AD, Tuyishimire B, Lin J, Kong AL.) J Clin Oncol. 2014 Sep 10;32(26_suppl):83.
The significance of margin status in patients with DCIS undergoing breast-conserving surgery.

(Currey AD, Forrester J, Tuyishimire B, Lin J, Kong AL.) J Clin Oncol. 2014 Sep 10;32(26_suppl):98.
Benign breast disease.

(Amin AL, Purdy AC, Mattingly JD, Kong AL, Termuhlen PM.) Surg Clin North Am. 2013 Apr;93(2):299-308.